Mackenzie Financial’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,059
| Closed | -$328K | – | 1609 |
|
|
2024
Q2 | $328K | Hold |
6,059
| – | – | ﹤0.01% | 1137 |
|
|
2024
Q1 | $425K | Hold |
6,059
| – | – | ﹤0.01% | 1054 |
|
|
2023
Q4 | $506K | Buy |
+6,059
| New | +$506K | ﹤0.01% | 995 |
|
|
2023
Q3 | – | Sell |
-6,059
| Closed | -$202K | – | 1497 |
|
|
2023
Q2 | $202K | Buy |
+6,059
| New | +$202K | ﹤0.01% | 1335 |
|
|
2023
Q1 | – | Sell |
-5,139
| Closed | -$235K | – | 1540 |
|
|
2022
Q4 | $235K | Sell |
5,139
-271
| -5% | -$12.4K | ﹤0.01% | 1176 |
|
|
2022
Q3 | $262K | Sell |
5,410
-54,171
| -91% | -$2.62M | ﹤0.01% | 1140 |
|
|
2022
Q2 | $2.34M | Buy |
+59,581
| New | +$2.34M | ﹤0.01% | 687 |
|